SCHEMBL3249157

SCHEMBL3249157

C/[C]=C(\C)CCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21274064 1.00
SCHEMBL3249155 1.00
SCHEMBL4863800 0.97 CES2 (0.46)
SCHEMBL7187122 0.97 CES2 (0.46)
SCHEMBL3648860 0.97 CES2 (0.46)
SCHEMBL7176117 0.97 CES2 (0.46)
SCHEMBL7181805 0.97 CES2 (0.46)
SCHEMBL7177933 0.97 CES2 (0.46)
SCHEMBL3648861 0.97 CES2 (0.46)
SCHEMBL7188649 0.97 CES2 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112313221-A Cannabinoid derivatives and conjugates and uses thereof 比托邦制药有限公司 2021-02-02 CN claimed
US-20210009549-A1 CANNABINOID DERIVATIVES AND CONJUGATES AND USES THEREOF BEETLEBUNG PHARMA LTD (IL) 2021-01-14 US claimed
WO-2019159168-A1 CANNABINOID DERIVATIVES AND CONJUGATES AND USES THEREOF BEETLEBUNG PHARMA LTD. (IL) 2019-08-22 WO claimed
CN-118338899-A Cannabidiol (CBD) and terpene formulations for increasing restorative sleep in humans 定义研究公司 2024-07-12 CN disclosed
US-20210289794-A1 COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-23 US disclosed
CN-112313221-A Cannabinoid derivatives and conjugates and uses thereof 比托邦制药有限公司 2021-02-02 CN disclosed
US-20210009549-A1 CANNABINOID DERIVATIVES AND CONJUGATES AND USES THEREOF BEETLEBUNG PHARMA LTD (IL) 2021-01-14 US disclosed
WO-2019159168-A1 CANNABINOID DERIVATIVES AND CONJUGATES AND USES THEREOF BEETLEBUNG PHARMA LTD. (IL) 2019-08-22 WO disclosed
US-8258322-B2 Synthesis of hexahydrodibenzopyranones WATSON LABORATORIES, INC. (US) 2012-09-04 US disclosed
CN-102131795-A Improved synthesis of hexahydrodibenzopyranones DALTON CHEMICAL LAB INC 2011-07-20 CN disclosed
EP-1920042-B1 PARTICLES CONTAINING PERFUME HAVING IMPROVED FRAGRANCED PROPERTIES HENKEL AG & CO KGAA (DE) 2010-06-23 EP disclosed
US-4152451-A HYPOTENSIVE AGENTS ELI LILLY AND COMPANY (US) 1979-05-01 US disclosed
US-4148809-A Process for preparing dl-cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones ELI LILLY AND COMPANY (US) 1979-04-10 US disclosed
US-4140701-A 2,6-Methano-2H-1-benzoxocins ELI LILLY AND COMPANY (US) 1979-02-20 US disclosed
US-4131614-A Process for preparing cis-hexahydrodibenzopyranones ELI LILLY AND COMPANY (US) 1978-12-26 US disclosed
US-4102902-A Stereoselective preparation of hexahydro dibenzopyranones and intermediates therefor ELI LILLY AND COMPANY (US) 1978-07-25 US disclosed
US-4075230-A Preparation of optically active trans-hexahydrodibenzopyranones ELI LILLY AND COMPANY (US) 1978-02-21 US disclosed
US-4054583-A Process for converting 2,7-dihydroxy-5-isopropylidene-9-substituted-2,6-methano-3,4,5,6-tetrahydro-2H-1-benzoxocin to trans-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo(b,d)pyran-9-one ELI LILLY AND COMPANY (US) 1977-10-18 US disclosed
US-4054582-A Process for converting cis-hexahydrodibenzo[b,d]pyran-9-ones to trans-hexahydrodibenzo[b,d]-pyran-9-ones ELI LILLY AND COMPANY (US) 1977-10-18 US disclosed
US-3962448-A CNS DEPRESSANTS, VETERINARY SMITHKLINE CORPORATION (US) 1976-06-08 US disclosed